Revolutionizing cardiovascular medicine: targeted therapies for the cardiac conduction system

Arrhythmogenic cardiovascular disorders are associated with considerable morbidity and mortality. Whether cardiac conduction disease is caused by genetic defects, procedural perturbations, valvular disease, ischemia, aging, or heart failure, new therapies are warranted. In this issue of the JCI, Goo...

Descripción completa

Detalles Bibliográficos
Autores principales: Garry, Daniel J., Yannopoulos, Demetris, Alexy, Tamas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566887/
https://www.ncbi.nlm.nih.gov/pubmed/36250459
http://dx.doi.org/10.1172/JCI164192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566887/
https://www.ncbi.nlm.nih.gov/pubmed/36250459
http://dx.doi.org/10.1172/JCI164192

Ejemplares similares